Christopher Astle

Insider Reports History

Location
Vancouver, British Columbia, Canada
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Astle:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zymeworks Inc. SVP & Chief Financial Officer Restricted Stock Unit 30,000 $336,468 $11.22 05 Jan 2024 Direct
Zymeworks Inc. SVP & Chief Financial Officer Common Stock 6,503 $72,935 $11.22 08 Jan 2024 Direct
Zymeworks Inc. SVP & Chief Financial Officer Stock Option (Right to Buy) 125,000 10 Mar 2022 Direct
Zymeworks Inc. SVP & Chief Financial Officer Stock Option (Right to Buy) 50,000 05 Jan 2024 Direct

Insider Reports Filed by Christopher Astle

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZYME Zymeworks Inc. 05 Jan 2024 6 -$64,656 4 SVP & Chief Financial Officer 08 Jan 2024, 18:14
ZYME Zymeworks Inc. 11 Dec 2023 3 -$8,089 4 SVP & Chief Financial Officer 11 Dec 2023, 20:00
ZYME Zymeworks Inc. 05 Jan 2023 2 $0 4 SVP & Chief Financial Officer 06 Jan 2023, 19:00
ZYME Zymeworks Inc. 12 Dec 2022 3 -$5,331 4/A SVP & Chief Financial Officer 23 Dec 2022, 19:00
/report/000089924322010796-astle-christopher-2022-03-10 Zymeworks Inc. 10 Mar 2022 1 $0 4 SVP & Chief Financial Officer 11 Mar 2022, 20:00
/report/000089924322009585-astle-christopher-2022-02-24 Zymeworks Inc. 24 Feb 2022 0 $0 3 SVP & Chief Financial Officer 04 Mar 2022, 20:20